ArticleCurrent oncology (Toronto, Ont.)2023

Effectiveness of Immune Checkpoint Inhibitor with Anti-PD-1 Monotherapy or in Combination with Ipilimumab in Younger versus Older Adults with Advanced Melanoma.

Taylor E Woo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.